URMC /Research / Research@URMC

Featured Blog Post Image

Telomeres Might Predict Lung Cancer Recurrence

Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.

Weather Map Lookalike Tracks Heart Problems, not Sun or Snow

A U.S. patent has been issued for a tool invented at URMC that helps to identify people at high or low risk for heart attacks.

4/15/2015 | 0 comments

Cardiac Trainee Wins Young Investigator Award from American Physiological Society

David Auerbach, Ph.D., a trainee at the Aab Cardiovascular Research Institute, won the Clinical Science Young Investigator Award – Cardiovascular Section from the American Physiological Society, which recognizes an outstanding junior investigator involved in cardiovascular research. 

4/14/2015 | 0 comments

Saliva: Taken for Granted Until It’s Not Produced

For years scientists have been searching for salivary gland stem cells as the panacea to restore saliva for head-and-neck cancer patients suffering from dry mouth due to radiation treatment. But new research at the University of Rochester shows that just like the liver and pancreas, it appears the salivary glands are maintained without the support of a stem cell pool.

4/7/2015 | 0 comments

Dworkin Wins Award for Major Achievements in Pain Research

Robert Dworkin, Ph.D. received the 2015 Mitchell B. Max Award for Neuropathic Pain from the American Academy of Neurology for his outstanding contributions to research in the field. Dworkin’s most notable achievements include his efforts to improve the methods used to evaluate and approve new, safe, and effective treatments for the more than 100 million Americans who report having chronic pain.  

4/7/2015 | 0 comments

Pathologist Wins Breast Cancer Award to Study Bone Metastasis

A University of Rochester Medical Center scientist, who is studying an “all-in-one” agent to be used when breast cancer spreads to the bone, received a $50,000 grant today from the Breast Cancer Coalition of Rochester (BCCR).

3/24/2015 | 0 comments